Boston Scientific CEO Michael Mahoney's 2022 pay rises 5% to $17M
Boston Scientific reports 2022 executive compensation
By ExecPay News
Published: March 22, 2023
Boston Scientific reported fiscal year 2022 executive compensation information on March 22, 2023.
In 2022, five executives at Boston Scientific received on average a compensation package of $6.9M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Boston Scientific
Michael F. Mahoney, Chief Executive Officer, received $17M in total, which increased by 5% compared to 2021. 59% of Mahoney's compensation, or $9.9M, was in stock awards. Mahoney also received $377K of change in pension value and nonqualified deferred compensation earnings, $2.3M in non-equity incentive plan, $2.9M in option awards, $1.4M in salary, as well as $93K in other compensation.
For fiscal year 2022, the median employee pay was $76,054 at Boston Scientific. Therefore, the ratio of Michael F. Mahoney's pay to the median employee pay was 223 to one.
Daniel J. Brennan, Chief Financial Officer, received a compensation package of $5.3M, which increased by 19% compared to previous year. 49% of the compensation package, or $2.6M, was in stock awards.
Joseph M. Fitzgerald, Executive Vice President and Group President, Cardiology, earned $4.8M in 2022, a 11% increase compared to previous year.
Arthur C. Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific, received $4.2M in 2022.
Jeffrey B. Mirviss, Executive Vice President and President, Peripheral, earned $3.6M in 2022, a 3% increase compared to previous year.
Related executives
Michael Mahoney
Boston Scientific
Chief Executive Officer
Daniel Brennan
Boston Scientific
Chief Financial Officer
Arthur Butcher
Boston Scientific
Executive Vice President and Group President, MedSurg and Asia Pacific
Joseph Fitzgerald
Boston Scientific
Executive Vice President and Group President, Cardiology
Jeffrey Mirviss
Boston Scientific
Executive Vice President and President, Peripheral
You may also like
Source: SEC filing on March 22, 2023.